Answers are grounded in this paper and cite their sources.
ROTEM-guided haemostatic therapy, with fibrinogen concentrate as first-line haemostatic therapy and additional PCC, was goal-directed and fast. A favourable survival rate was observed. Prospective, randomized trials to investigate this therapeutic alternative further appear warranted.
No takes yet. Share an insight, caveat, or question.
Schöchl et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: